Form EFFECT ASLAN Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 29, 2024 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Children of Centenarians Often Live Longer, Develop Some Age-Related Diseases Later
- Thurston Group Partners with Pixel Health, a Leading Healthcare IT Consulting and Managed Services Provider
- New Crypto: Pepeto Presale Announces $10.85M As the Ethereum Price Prediction Calls $7,500
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
